Monogram Orthopaedics
MGRM
MGRM was delisted on the 6th of October, 2025.
42 hedge funds and large institutions have $5.42M invested in Monogram Orthopaedics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 5 closing their positions.
53% more capital invested
Capital invested by funds: $3.55M → $5.42M (+$1.87M)
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
0.86% more ownership
Funds ownership: 4.36% → 5.22% (+0.86%)
11% less funds holding
Funds holding: 47 → 42 (-5)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$637K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$145K |
| 3 |
State Street
Boston,
Massachusetts
|
+$122K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$45K |
| 5 |
Two Sigma Investments
New York
|
+$40.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFO
Fiduciary Family Office
Boca Raton,
Florida
|
-$69.6K |
| 2 |
Barclays
London,
United Kingdom
|
-$28.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$10.7K |
| 4 |
HNB
Huntington National Bank
Columbus,
Ohio
|
-$3.31K |
| 5 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$2.64K |
MGRM Hedge Fund Activity: Q1 2025 in Review
42 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Monogram Orthopaedics (MGRM) for Q1 2025, worth a combined $5.42M — up 53% from $3.55M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MGRM and 2 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 11 added.
The largest buyer was Vanguard Group, adding an estimated $637K. The largest seller was Fiduciary Family Office, exiting entirely with an estimated $69.6K sold.
- 42 institutional investors held Monogram Orthopaedics (MGRM) as of Q1 2025, down from 47 in Q4 2024.
- Funds reported $5.42M of Monogram Orthopaedics stock for Q1 2025, up 53% quarter-over-quarter.
- 2 funds opened new Monogram Orthopaedics positions in Q1 2025 and 5 closed out, a net change of -3 holders.
- The largest Monogram Orthopaedics buyer in Q1 2025 was Vanguard Group, an estimated $637K added.
- The largest Monogram Orthopaedics seller in Q1 2025 was Fiduciary Family Office, an estimated $69.6K sold.
Based on aggregated 13F filings for Q1 2025.